<DOC>
	<DOCNO>NCT02881502</DOCNO>
	<brief_summary>Program： Clinical Study Relationship Between Granulocyte Activation , HDAC2 Severe Asthma Aim：The early prediction severe asthma , early intervention disease , reduce family national finance . design : This study single center randomize controlled trial design Department respiratory medicine , Xijing Hospital , main research unit.Compare case group ( severe asthma group mild-and-moderate asthma group ) control group ( healthy control group ) detect activity MPO、NE、MMP-9 ECP peripheral blood activity HDAC2 PBMCs patient . case:60 Case selection : Inclusion criterion : age 18-75 year old ; diagnosis asthma clear ; inform consent sign . Exclusion criterion : poor compliance ; cognitive ability low ; psychiatric disorder need combine psychotropic medication .</brief_summary>
	<brief_title>Clinical Study Relationship Between Granulocyte Activation , HDAC2 Severe Asthma</brief_title>
	<detailed_description>Application SPSS 19 statistical software . Measurement data express mean ± standard deviation . First data normality test homogeneity variance test , accord measurement data normal distribution SNK single factor analysis variance ; conform normal distribution measurement data , use Kruskal Wallis non parametric test . P &lt; 0.05 difference statistically significant .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>inclusion criterion : healthy control group： Mainly student , family member patient without chronic lung disease , healthy population , age 1875 year old , gender limit . case group： The patient diagnose asthma outpatient clinic . The diagnostic criterion accordance Guidelines Prevention Treatment Bronchial Asthma respiratory disease branch Chinese Medical Association . In past 1 year need guideline global asthma record instrument 45 drug treatment asthma [ high dose inhale corticosteroid longacting beta2 receptor agonist leukotriene modifier / theophylline systemic hormone therapy equal 50 % time , order prevent uncontrolled asthma , even treatment control asthma patient severe asthma . exclusion criteria： Poor treatment compliance , low cognitive ability impact self rating scale ; There serious heart , liver , renal dysfunction , infectious disease ; The individual refuse sign inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>granulocyte activation</keyword>
	<keyword>HDAC2</keyword>
	<keyword>severe asthma</keyword>
</DOC>